SHREYAS COLLEGE OF NURSING

G.E. ROAD SUPELA, BHILAI

TOOL PRESENTATION ON:
TITLE :
"A PRE EXPERIMENTAL STUDY TO ASSESS THE
EFFECTIVENESS OF PLANNED TEACHING
PROGRAMME ON KNOWLEDGE REGARDING
NEBULIZATION THERAPY IN ASTHMATIC
CHILDREN (5 to 10 years) AMONG STAFF NURSES AT
DISTRICT HOSPITAL DURG(C.G)"

ADVISOR : Mr. ABHISHEK JACOB

PRINCIPAL
M.SC NSG, (MHN)

GUIDE : Mrs. CHITRA RAWANI

M.SC NSG. ASSOCIATE PROF. (C.H.N)

CO GUIDE : Mr. ABHISHEK JACOB

PRINCIPAL
M.SC NSG,(MHN)

SUBMITTED BY : MRS. SUNITA KULARKAR

M.SC NSG FINAL YEAR SCON

BATCH : 2014-2016
PROBLEM STATEMENT
"A PRE EXPERIMENTAL STUDY TO ASSESS THE EFFECTIVENESS OF PLANNED
TEACHING PROGRAMME ON KNOWLEDGE REGARDING NEBULIZATION THERAPY
IN ASTHMATIC CHILDREN (5 to 10 years) AMONG STAFF NURSES WORKING IN
PEDIATRIC UNIT IN SELECTED HOSPITALS DURG (C.G.)"

OBJECTIVES:
1. To assess the pre test and post test level of knowledge among staff nurses regarding
nebulization therapy in asthmatic Children.
2. To assess the effectiveness of planned teaching programme by comparing pre test and
post test level of knowledge among staff nurses regarding nebulization in asthmatic
children.
3. To find out the association between pre test and post test level of knowledge among
staff nurses regarding nebulization therapy with their selected socio demographic
variables.

HYPOTHESIS:

1. H0: There will be no significant difference between pre test and post test knowledge
score among staff nurses at selected hospital durg (C.G.) as measured by knowledge
questionnaire at P<0.05 level
2. H1: There will be significant difference between pretest and post test knowledge score
among staff nurses at selected hospital durg (C.G.) as measured by knowledge
questionnaire at P>0.05 level
 SECTION-I
SOCIO DEMOGRAPHIC VARIABLES

1. Age in years
a) 21-25 years
b) 26-30 years
c) 31-35 years
d) 35 & above

2. Educational qualification
a) Diploma
b) Graduate
c) Post graduate

3. Designation
a) Staff nurse
b) Sister incharge

4. Religion
a) Hindu
b) Muslim
c) Christian
d) Others

5. Total Year of experience

a) 0-3 years
b) 4-6 years
c) 7-9 years
d) More than 9 years

6. Year of experience in pediatric unit

a) 0-2 years
b) 2-3 years
c) 3-4 years
d) More than 5 years
7. Previous knowledge regarding nebulization therapy in asthmatic Children.
a) Yes
b) No
If yes source of information regarding nebulization therapy in asthmatic Children.
a) curriculum
b) Mass media

8. Assisted asthmatic cases in pediatric unit

a) <10
b) 10-20
c) 20-30
d) >30
 SECTION-II

QUESTIONNAIRE REGARDING NEBULIZATION THERAPY

OF ASTHMATIC CHILDREN

NEBULIZATION THERAPY

Q.NO.01. Nebulization therapy means -

a) Process of medication administration via oral

b) Process of medication administration via inhalation
c) Process of medication administration via sublingual
d) Process of medication administration via injection

Q.NO.02. Nebulization machine is used to -

a) treat lung condition such as asthma and respiratory illness

b) treat lung condition such as respiratory distress.
c) treat lung condition such as rhinitis.
d) treat lung condition such as respiratory depression.

Q.NO.03. Purpose of nebulization therapy -

a) Inhaler device used to treat airway

b) Inhaler device used to treat asthma and allergies
c) Inhaler device used to treat heart
d) Inhaler device used to treat chest pain

Q.NO.04. Indications of nebulization therapy -

a) Viral hepatitis
b) Dengue fever
c) Pneumonia, & broncho-spasm
 d) High grade fever

Q.NO.05. Contraindications of nebulization therapy -

a) Increase blood pressure with decreased pulse rate

b) Increase blood pressure with increased pulse rate
c) Decreased blood pressure with increase pulse rate
d) Decreased blood pressure with decrease pulse rate

Q.NO.06. Use of nebulization therapy–

a) Converting liquid medication into a mist

b) Converting solute medication into a liquid
c) Converting solution into a powdered form
d) Converting liquid into solvents

Q.NO.07. Solution used for cleaning the nebulizer –

a) Distilled white vinegar with warm tap water

b) Sodium bi carbonate with warm tap water
c) Distiller white vinegar with normal water
d) Phenol with warm tap water

Q.NO.08. Position used for giving nebulization therapy -

a) Supine
b) Prone
c) Semi fowler’s
d) Side lateral
Q.NO.09. Nebulization therapy you should monitor -

a) Record breath sound, respiratory status and pulse rate

b) Record temperature
c) Record weight
d) Record physical examination

Q.NO.10. First step of providing nebulization therapy –

a) Assess vital signs

b) Hand washing
c) Prepare the patient
d) Clean the nebulizer

Q.NO.11. Second step to set up and use of nebulization therapy-

a) Connect the hose to an air compressor

b) Connect the tubing
c) Connect the oxygen
d) Provide medications

Q.NO.12. Third step to set up and use of nebulization therapy –

a) Attach the mouth piece with medicine cap

b) Fill the medicine cup with your prescription
c) Attach the oxygen tube
d) Place the mouthpiece in your mouth

Q.NO.13. Fourth step to set up and use of nebulization therapy –

a) Attach the hose and mouth piece to the medicine cup

b) Attach the hose with connecting tubes
 c) Attach the tube with oxygen mask
d) Provide position

Q.NO.14. Fifth step of nebulization therapy –

a) Attach the mouth piece with connector

b) Place the mouth piece in mouth
c) Attach the oxygen tube
d) Attach the mouth piece

Q.NO.15. Sixth step of nebulization therapy –

a) Provide position
b) Check the tubing
c) Breathe through mouth until all the medicine is used
d) Attach the tube

Q.NO.16. Solutions used in the nebulization therapy -

a) Potassium chloride (0.5%)

b) Sodium bi carbonate (0.4%)
c) Chlorine
d) Sodium chloride (0.9%)

Q.NO.17. Types of nebulizer medications -

a) Voveron
b) Acetylcysteine, albuterol, tobramycin & asthalin
c) Paracetamol
d) Ondansterone
Q.NO.18. Action of acetylcysteine is used to reduce-

a) Respiratory tract secretions

b) Treat kidney diseases
c) Treat cancer
d) Treat heart rate

Q.NO.19. Action of albuterol -

a) Act as antiemetic
b) Act as bronchodilator
c) Act as antipyretic
d) Act as analgesics

Q.NO.20. Side effect of albuterol –

a) Sleep problem & sore throat

b) Wheezing & vertigo
c) Sneezing & fainting
d) Cough and cold

Q.NO.21. Combination of drugs used is nebulization therapy –

a) Ipartropium bromide and albuterol sulphate

b) Asthalin and budecort
c) Asthalin and albuterol
d) Albuterol and budecort

Q.NO.22. Action of prednisolone –

a) To treat asthma attacks

b) To treat cardiac problem
 c) To treat gastro intestinal problem
d) To treat endocrine problem

Q.NO.23. Side effect of prednisolone –

a) Acne & weight gain

b) Weight loss & anorexia
c) Vertigo & fainting
d) Nausea & vomiting

Q.NO.24. Common dose of ipartropium bromide in Age (5 to 10) years –

a) 0.25mg
b) 0.3mg
c) 0.4mg
d) 0.5mg

Q.NO.25. Common dose of albuterol sulphate in Age (5 to 10) years –

a) 1.0mg
b) 2.5mg
c) 3.0mg
d) 4.0mg

Q.NO.26. Drugs come under corticosteroids –

a) Asthalin
b) Albuterol sulphate
c) Budesonide
d) Ipartropium bromide
Q.NO.27. Common dose of budesonide in Age (5 to 10) years –

a) 0.15mg
b) 0.25mg
c) 0.35mg
d) 0.5mg

Q.NO.28. Action of corticosteroids-

a) Prevents wheezing and shortness of breath

b) Prevent cyanosis
c) Prevent headache
d) Prevent vomiting

Q.NO.29. Common nebulizers used in the hospital -

a) Basic nebulizer
b) Normal nebulizer
c) Basic jet nebulizer
d) None of the above

Q.NO.30. Three components used in the nebulization therapy -

a) Chamber, mouth piece and tubing

b) Oxygen mask & tubing
c) Only oxygen mask
d) Mouth piece with tubing

Q.NO.31 .Flow rate for providing nebulization therapy-

a) 1-4l/minute
 b) 2-5l/minute
c) 4-8l/minute
d) 6-8l/minute

Q.NO.32. Time duration for providing nebulization therapy -

a) 1-3minutes
b) 5-10minutes
c) 2-5minutes
d) 1-10minutes

Q.NO.33. Site of placing face mask while doing nebulization therapy -

a) 1cm below the face

b) 1cm above the face
c) 0.5cm below the face
d) 0.5cm above the face

Q.NO.34. Inhaler is medical device used for –

a) Delivering medication into the body via the lungs

b) Delivering medication into the body via the liver
c) Delivering medication into the body via the kidney
d) Delivering medication into the body via the heart

Q.NO.35. Advantages of nebulizer treatment –

a) Cures the breathing problem

b) Cures the problem of abdominal distension
c) Cures the problem of weakness
d) Cure the liver disease
Q.NO.36. Disadvantage of nebulization therapy-

a) Chances of carrying infection from unsterile chambers or tubing

b) Useful in an acute attack situation
c) Chances of cyanosis
d) Chances of excessive sneezing

Q.NO.37. Side effects of nebulization therapy –

a) fever
b) Sneezing, itchy nose & watery eyes
c) Cough and cold
d) Bodyache

Q.NO.38. Side effect of bronchodilators -

a) Decreased pulse rate

b) Increase pulse rate
c) Increase heart rate
d) Decrease blood pressure

Q.NO.39. After care of articles –

a) Clean the mouth piece & medicine cup with water

b) Wash the medicine cup & mouthpiece with water and air dry
c) Clean the mouth piece with gauze piece
d) Clean the medicine cup with gauze piece

Q.NO.40. Long-term controller of asthmatic children -

a) Medicines taken two times for asthma

b) Medicines taken three times for asthma
 c) Medicines taken bed time for asthma
d) Medicines taken daily for asthma

Q.NO.41. Complications of nebulization therapy –

a) Palpitation, tachycardia, & tremors

b) Dizziness, vertigo & bradycardia
c) Tachypnea & tachycardia
d) Vertigo & bradycardia
 LIST OF REFERENCES

1. American Lung Association. Trends in asthma morbidity and mortality. American Lung

Association Epidemiology & Statistics Unit Research and Program Services. November

2007.

2. www.asthmahelpline.com/asthma-introduction.htm

3. www.breathefree.com/asthma-treatment-and-control.html

4. American Lung Association. Epidemiology & Statistics Unit, Research and Program

Services. Trends in Asthma Morbidity and Mortality, November 2007.

5. World Health Organization. Global surveillance, prevention and control of chronic

respiratory diseases: a comprehensive approach, 2007.

6. Centers for Disease Control. National Surveillance for Asthma - United States, 1980-

2004 MMWR, 2007; 56(SS08);1-14;18-54.

7. Martinez FD, Wright AL, Taussig LM, et al. Asthma and wheezing in the first six years

of life, N Engl J Med 1995; 332:133-138.

8. Akinbami, L. Asthma prevalence, health care use and mortality: United States 2003-05,

CDC National Center for Health Statistics, 2006.

9. American Lung Association, Epidemiology and Statistics Unit, Research and Program

Services. Trends in Asthma Morbidity and Mortality. November 2007. (ALA age group

analysis of NHIS through 2005.

10. Global Initiative for Asthma. National Institute of Health. National Heart, Lung and

Blood Institute Publication No. 02-3659 .